Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...
Four months after Theravance Biopharma shut down its R&D unit, laid off half its staff and signaled it was up for sale, the ...
In rejecting NASP, the FDA is delaying the launch of a gout drug that Sobi projected could reach up to 6 billion Swedish kroner ($620 million) in peak sales. (Photo by Sarah Silbiger/Getty Images) ...
The world’s first CAR-T therapy for solid tumors has passed muster in China, with the country's National Medical Products ...
The European Commission has kicked off formal proceedings in an antitrust investigation against Sanofi. The probe surrounds ...
Once the CHMP has delivered marketing authorization recommendations, final sign-off on the decisions must still be conferred ...
In the past two weeks, CARsgen Therapeutics won the world's first regulatory approval for a solid tumor CAR-T Biologics' ...
The transaction is a big splash for Merck KGaA, representing the company’s largest deal since its buyout of Sigma-Aldrich for ...
As a sweltering heat wave hit Europe, a swath of pharma companies and healthcare marketing agencies from around the world ...
Bayer has scored a key victory in its defense against Roundup lawsuits as the U.S. Supreme Court has tossed a $1.25 million ...
Driven by personal losses, major unmet needs and a desire to diversify from the crowded oncology market, Fosun Pharma is ...
He added that the company's plan to sell Foundayo through government channels will depend on the pricing implications of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results